Stock analysts at Zacks Research increased their Q1 2025 earnings per share estimates for BioMarin Pharmaceutical in a ...
Zacks Research cut their Q4 2026 earnings per share (EPS) estimates for shares of Ubiquiti in a report issued on Wednesday, ...
Opinion
Zacks Investment Research on MSN4dOpinion
Top Research Reports for Bank of America, Accenture & ServiceNow
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Bank of America Corp. (BAC), ...
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research ...
Opinion
Zacks Investment Research on MSN9dOpinion
Top Research Reports for Walmart, HSBC & Adobe
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Walmart Inc. (WMT), HSBC Holdings plc ...
A recent ransomeware attack targeted Zacks, an American investment firm, and a cybercriminal claimed to have stolen records ...
ACM Research (ACMR) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
SAN DIEGO (AP) — SAN DIEGO (AP) — Atyr Pharma Inc. (ATYR) on Thursday reported a loss of $15 million in its fourth quarter. The San Diego-based company said it had a loss of 18 cents per share.
ROCKVILLE, Md. (AP) — ROCKVILLE, Md. (AP) — Regenxbio Inc. (RGNX) on Thursday reported a loss of $51.2 million in its fourth quarter. On a per-share basis, the Rockville, Maryland-based company said ...